First Time Myocardial Infarction in a Rheumatic Patient After Elective Arthroplasty

HSS Journal

Volumn 9, Issue 2, 2013, Pages 203-207

  Calloway, James J ^a,b   Goodman, Susan M ^a,b   Hollomon, Wesley ^a,b   Russell, Linda A ^a,b   Krauser, Daniel ^a,c  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

C reactive protein (CRP); coronary heart disease (CHD); rheumatoid arthritis (RA)

Indexed keywords

EID: 84880507839     PISSN: 15563316     EISSN: 15563324     Source Type: Journal    
DOI: 10.1007/s11420-012-9309-5     Document Type: Review

References (28)

1. Akkara Veetil BM, Bongartz T. Perioperative care for patients with rheumatic diseases. Nat Rev Rheumatol. 2012;8: 32-41.
2. Aubry MC, Mardit-Kremers H, Reinalda MS, Crowson CS, Edwards WD, Gabriel SE. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol. 2007;34: 937-42.
3. Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59: 1690-1697.
4. Devereaux PJ, Yang H, Yusuf S, et al. POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomized controlled trial. Lancet. 2008;371(9627): 1839.
5. Fayad Z, Fuster V, Fallon JT, et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation. 2000;102: 506-510.
6. Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum. 1993;36(6): 729.
7. Fischer LM, Schlienger RG, Matter C, Jick H, Meier CR. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first time acute myocardial infarction. Am J Cardiol. 2004;93: 198-200.
8. Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J AM Coll Cardiol. 2009;54(22): e19-e44.
9. Galvin EM, O'Donnell D, Leonard IE. Rheumatoid arthritis: A significant but often underestimated risk factor for perioperative cardiac morbidity. Anesthesiology. 2005;103: 910-11.
10. Greenberg JD, Kremer JM, Curtis JR, et al. Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70: 576-582.
11. Houten JK, Tandon A. Comparison of postoperative values for c-reactive protein in minimally invasive and open lumbar spinal fusion surgery. Surg Neurol Int. 2011;2: 94.
12. Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased Unrecognized Coronary Heart Disease and Sudden Deaths in Rheumatoid Arthritis. Arthritis Rheum. 2005;52: 402-411.
13. McCarey DW, McInnes IB, Madhok R, et al. Trial of atorvastatin in rheumatoid arthritis (TARA): double-blind, randomized placebo controlled trial. Lancet. 2004;363(9426): 2015-2021.
14. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365: 2205-2219.
15. Motoyama S, Sarai M, Harigaya H, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol. 2009;54(1): 49.
16. Naranjo A, Sokka T, Descalzo MA, et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the Quest-RA study. Arthritis Res Ther. 2008;10(2): 105.
17. Oscarsson A, Gupta A, Fredrikson M, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth. 2010;104(3): 305-12.
18. Peters MJL, Symmons DPM, McCarey D, et al. EULAR evidence- based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2010;68: 325-331.
19. Provan SA, Semb AG, Hisdal J, et al. Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross sectional comparative study. Ann Rheum Dis. 2011;70: 812-817.
20. Ridker PM, Danielson E, Fonseca FAH, et al. Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein. N Engl J Med. 2008;359: 2195-2207.
21. Roman MJ, Moeller E, Davis A, et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med. 2006;144: 249-256.
22. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340: 115-126.
23. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107: 1303-1307.
24. Solomon DH, Kremer JM, Curtis JR, et al. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis. 2010;69: 1920-1925.
25. Urban MK, Jules-Elysee K, Loughlin C, Kelsey W, Flynn E. The one year incidence of postoperative myocardial infarction in an orthopedic population. HSS J. 2008;4: 76-80.
26. van Halm VP, Peters MJL, Voskuyl AE, et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross sectional study, the CARRÉ Investigation. Ann Rheum Dis. 2009;68: 1395-1400.
27. Urban MK, Jules-Elysee KM, Beckman JB, et al. Pulmonary injury in patients undergoing complex spine surgery. The Spine Journal. 2005;5: 269-276.
28. US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;150(6): 396.